Product Description: Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection[1].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Markham A. REGN-EB3: First Approval. Drugs. 2021 Jan;81(1):175-178.